(IN BRIEF) A recent study conducted by researchers from the University of Southampton and the University of Bergen reveals that boys who smoke during their early teenage years are at risk of damaging the genes of their future children. The … Read the full press release
Posted in Business, Education, Healthcare, Management, News, Science, United Kingdom
Tagged asthma, Boys, Dr Gerd Toril Mørkve Knudsen, Dr Kath Woods-Townsend, Dr Negusse Kitaba, Future Children, Health Risks, Obesity, Professor Cecilie Svanes, Professor John Holloway, smoking, Teenager, University of Bergen, University of Southampton Study, vaping, wellness, wheezing
(IN BRIEF) New research from the University of East Anglia has found that being vaccinated against Covid-19 can halve the risk of developing long Covid. The study, which is the largest of its kind and includes more than 860,000 patients, … Read the full press release
Posted in Education, Healthcare, Management, Media, News, Science, United Kingdom
Tagged anxiety, asthma, comorbidities, COPD, coronary heart disease, depression, Dr Eleana Ntatsaki, hospitalisation, immunosuppression, long Covid, overweight, Prof Vassilios Vassiliou, risk factors, smokers, study, type 2 diabetes, University of East Anglia, vaccinated, WOMEN
(PRESS RELEASE) CAMBRIDGE, 13-Jan-2023 — /EuropaWire/ — AstraZeneca (LSE/STO/Nasdaq: AZN), a British-Swedish multinational pharmaceutical and biotechnology company, has announced that its drug Tezspire (tezepelumab) has been given the green light for self-administration by the European Medicine Agency’s Committee for Medicinal … Read the full press release
Posted in European Union, Healthcare, News, Pharma & Biotech, Science, Sweden, Technology, United Kingdom
Tagged allergic, asthma, asthma biologic, AstraZeneca, convenient pre-filled pen, EMA, eosinophilic, EU approval, Mene Pangalos, Professor Ian Pavord, self-administration, severe asthma patients, tezepelumab, Tezspire, University of Oxford
Dupixent ist das erste und einzige Medikament mit positiven Phase-3-Ergebnissen bei Prurigo nodularis, was den potenziellen Nutzen einer gezielten Behandlung von IL-4 und IL-13, zentralen Treibern von Typ-2-Entzündungen, zur Behandlung von Juckreiz und Hautläsionen bestätigt Die Daten bestätigen die Ergebnisse … Read the full press release
Posted in France, Healthcare, Pharma & Biotech, Science, Technology
Tagged anhaltender Juckreiz, asthma, Atemwegserkrankungen, atopische Dermatitis, dermatologische Erkrankungen, dupilumab, Dupixent, entzündliche Hauterkrankung, extremer Juckreiz, George D. Yancopoulos, Hauterkrankungen, Hautläsionen, Knötchen, Naimish Patel, prurigo nodularis, Regeneron, unerträglicher Juckreiz
Dupixent is the first and only medicine to demonstrate positive Phase 3 results in prurigo nodularis, confirming the potential benefit of targeting IL-4 and IL-13, central drivers of type 2 inflammation, to address itch and skin lesions Data confirm results … Read the full press release
Posted in France, Healthcare, News, Pharma & Biotech, Science, Technology
Tagged asthma, atopic dermatitis, CRSwNP, dermatological diseases, dupilumab, Dupixent, extreme itch, George D. Yancopoulos, inflammatory skin disease, Naimish Patel, nodules, persistent itch, prurigo nodularis, Regeneron, respiratory diseases, skin diseases, skin lesions, unbearable itch
(PRESS RELEASE) VEVEY, 14-Oct-2020 — /EuropaWire/ — Nestlé has successfully closed the acquisition of biopharmaceutical company, Aimmune Therapeutics, Inc. (Nasdaq: AIMT). The company which specializes in developing and bringing new treatments to people with potentially life-threatening food allergies joins Nestlé … Read the full press release
Posted in Investment, Management, News, Pharma & Biotech, Science, Switzerland
Tagged acquisition, Aimmune Therapeutics, allergic reactions, allergies, AlMab7195, anaphylaxis, Andrew Oxtoby, Arachis hypogaea, asthma, EM, Eosinophilic Gastrointestinal Disease, European Medicines Agency, FDA, Greg Behar, monoclonal antibody, Nestlé, Nestlé Health Science, NHSc, oral immunotherapy, PALFORZIA®, Peanut Allergen Powder-dnfp, Pharmaceutical, science-bassed nutritional solutions, Swiss Agency for Therapeutic Products, SwissMedic, treating peanut allergy
CAMBRIDGE, 07-Nov-2018 — /EuropaWire/ — AstraZeneca has entered into an agreement with Covis Pharma B.V. (Covis Pharma) to sell its rights to the medicines Alvesco (ciclesonide), used for the treatment of persistent asthma, and Omnaris and Zetonna (ciclesonide), used for the treatment of nasal symptoms associated with … Read the full press release
Posted in Healthcare, Pharma & Biotech, United Kingdom
Tagged Alvesco, asthma, AstraZeneca, Covis Pharma, Mark Mallon, Michael Porter, Omnaris, rhinitis, Zetonna
AstraZeneca’s first Breakthrough Therapy Designation for a respiratory medicine Designation based on Phase IIb PATHWAY data that demonstrated tezepelumab significantly reduced asthma exacerbations compared to placebo in severe asthma CAMBRIDGE, 12-Sep-2018 — /EuropaWire/ — AstraZeneca and its partner Amgen Inc. (Amgen) … Read the full press release
Posted in Healthcare, Pharma & Biotech
Tagged Amgen, asthma, AstraZeneca, breakthrough therapy designation, eosinophilic_phenotype, medicine, respiratory, Sean Bohen, tezepelumab
Results showed Dupixent demonstrated a significant improvement in multiple asthma endpoints in two Phase 3 clinical trials in a broad population of patients with uncontrolled asthma, irrespective of minimum baseline eosinophil levels or other biomarkers of Type 2 inflammation Greater … Read the full press release
Posted in France, Healthcare, Pharma & Biotech
Tagged asthma, corticosteroids, Dupixent, New England Journal of Medicine, Sanofi
Brentford, United Kingdom, 17-May-2018 — /EuropaWire/ — GlaxoSmithKline plc (GSK) will present extensive data from across its respiratory portfolio, pipeline and early phase research programmes at the American Thoracic Society (ATS) conference in San Diego, USA, 19-23 May 2018. Data presented … Read the full press release
Company opens new pollen measurement station at its Drachten innovation center in the Netherlands AMSTERDAM, 26-Apr-2018 — /EuropaWire/ — This World Allergy Week (April 22 – 28) and World Asthma Day (May 1), Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in … Read the full press release
Posted in Healthcare, Netherlands, Technology
Tagged allergy, allergy symptoms, asthma, children’s asthma, pollen, Roy Jakobs, Royal Philips, WorldAllergyWeek, WorldAsthmaDay
LEEDS, 02-Apr-2018 — /EuropaWire/ — New research suggests that up to 38% of all annual childhood asthma cases in Bradford may be caused by air pollution. The study, led by the University of Leeds, also shows traffic-related air pollution could be … Read the full press release
Posted in Education, Environment, Science, Technology, United Kingdom
Tagged air pollution, asthma, Bradford, childhood asthma, DR HANEEN KHREIS, Nitrogen Oxides
Not for audiences in the US and Canada LONDON, 26-8-2015 — /EuropaWire/ — This week, epgonline.org, the website for healthcare professionals, welcomes the launch of a free symptomatic asthma Continuing Medical Education (CME) activity, available at epgonline.org/symptomatic-asthma/cme/. Accredited by the … Read the full press release
Stockholm, Sweden, 24-3-2015 — /EuropaWire/ — Blueair, the world’s leading mobile indoor air purifying technologies company, Monday warned that indoor air in homes and offices can be many times more polluted than the air outside. Commenting on the recent severe smog … Read the full press release
Posted in Chemicals, Environment, France, Healthcare, News, Sweden, Technology, United Kingdom
Tagged 180 micrograms per cubic meter, air pollution, air pollution in London, air pollution in Paris, airborne pollutants, allergens, asthma, asthma triggers, bacteria, Bengt Rittri, blueair, blueair air purifiers, choking smog pollution, contaminants, David Noble, fine dust, indoor air, indoor air cleaning, indoor air purification, indoor air purifiers, indoor contaminants, mobile indoor air purifying, PM10 airborne particulates, PM2.5, smog, temporary traffic bans, viruses, volatile organic chemicals
LONDON, 6-8-2014 — /EuropaWire/ — Berlin’s annual IFA tech expo opens to the public on September 5 and this year global indoor air cleaning technology company Blueair unveils new ultra high performance technologies to clean the air of practically all … Read the full press release
Posted in Environment, Germany, Healthcare, Netherlands, News, Retail, Sweden, Technology, United Kingdom
Tagged air purifying appliances, airborne allergies, airborne pollutants, allergies, asthma, Bengt Rittri, Berlin’s IFA 2014 gadget show, blueair, healthy homes, healthy workplaces, IFA tech expo, indoor air cleaning technology, indoor air purification, indoor air quality, outdoor pollution, PM2.5, PM2.5 dust, VOCs
Holzkirchen, Germany, 31-1-2014 — /EuropaWire/ — Sandoz announced today it has received Romanian marketing authorization for AirFluSal® Forspiro®, an innovative new inhaler for patients with asthma and COPD. The product was first approved in Denmark on December 18th, 2013. The new product … Read the full press release
London, UK, 23-10-2013 — /EuropaWire/ — GlaxoSmithKline plc (LSE:GSK) today announced the submission of a New Drug Application (NDA) in the US for the once daily inhaled corticosteroid (ICS) treatment, fluticasone furoate (FF), administered using the ELLIPTA™ dry powder inhaler. The NDA … Read the full press release
Posted in Government, Healthcare, Pharma & Biotech, Science, United Kingdom
Tagged asthma, Bradd Pavur, Catherine Hartley, David Daley, David Mawdsley, ELLIPTA™, ELLIPTA™ dry powder inhaler, fluticasone furoate (FF), fluticasone furoate monotherapy, Gary Davies, GlaxoSmithKline, GlaxoSmithKline plc, GSK, James Dodwell, Jeff McLaughlin, Juan Carlos Molina, Karen Collins, Kirsty Collins (SRI & CG), LSE:GSK, Lucy Singah, Melinda Stubbee, NDA, New Drug Application (NDA), once daily inhaled corticosteroid (ICS) treatment, Simon Steel, Stephen Rea, Tom Curry, US FDA, US regulatory submission, Ziba Shamsi
12-8-2013 — /EuropaWire/ — Research led by University of Leicester health expert aims to speed up impact for patients across the region Issued by Nottinghamshire Heathcare NHS Trust on 9 August 2013 A collaboration between the NHS and universities across the … Read the full press release
Posted in Education, Financial, Healthcare, Science, United Kingdom
Tagged asthma, Ather Mirza, Diabetes, East Midlands patients, mental health issues, NIHR CLAHRC East Midlands, Nottinghamshire Healthcare, Primary Care Diabetes, Professor Kamlesh Khunti, Professor Khunti, Professor Mike Cooke, University of Leicester health reseach, Vascular Medicine, £28.4M funding
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions.
HOW TO GET STARTED?
PHARMA & BIOTECH: The largest repository of EU/European pharma & biotech press releases spanning 12 years (2012-2024)
